Buy SCRIMED
Choose a clear healthcare AI package your team can fund, review, and govern.
SCRIMED gives healthcare buyers a practical path from workflow pain to assessment, synthetic pilot, protected enterprise activation, or governance review, with deliverables, proof routes, price discipline, and boundaries visible before custom work begins.
From interest to purchase path
Every public demo now points to a package, price band, proof list, and no-PHI intake route.
CarePath Access Operations Demo
Access, care navigation, discharge, population health, and throughput leaders.
- Pilot: 60-Day Governed Automation Pilot
- No autonomous outreach, diagnosis, treatment, emergency routing, PHI, or live workflow execution.
DocuTwin Documentation Review Demo
Clinical documentation, ambulatory operations, quality, and CMIO teams.
- Pilot: 60-Day Governed Automation Pilot
- No final note, EHR filing, diagnosis insertion, autonomous documentation, PHI, or clinical validation claim.
PayerIQ Documentation Readiness Demo
Prior authorization, RCM, utilization-management, access, and finance transformation leaders.
- Pilot: 60-Day Governed Automation Pilot
- No live PHI, medical-necessity determination, payer submission, appeal filing, EHR writeback, or reimbursement guarantee.
TrialCore Research Operations Demo
Research operations, oncology programs, academic medical centers, and trial networks.
- Pilot: 60-Day Governed Automation Pilot
- No patient outreach, enrollment decision, treatment recommendation, PHI, or production research-record mutation.
Atlas Interoperability Readiness Demo
CIOs, integration leaders, EHR teams, health tech platforms, and security teams.
- Pilot: AI Governance + Interoperability Readiness Pilot
- No live healthcare data exchange, connector certification, trading-partner acceptance, or production mutation.
Canonical packaging rule
Every buyer conversation resolves to one package, one offer, one proof route, one margin control, and one retained boundary.
SCRIMED Product and Services Portfolio organizes sellable offers, service packages, delivery paths, proof routes, margin controls, qualification gates, and retained approval boundaries for governed synthetic evaluations, readiness work, protected pilots, and enterprise operating-layer expansion. It is product, service, and commercial operating readiness only. It is not legal advice, accounting advice, tax advice, audited financial reporting, securities offering material, investment advice, valuation assurance, customer permission, revenue guarantee, profit-margin guarantee, reimbursement assurance, clinical validation, compliance certification, security certification, PHI processing authority, production connector approval, EHR writeback approval, payer submission approval, or live clinical care authorization.
Packages
Offer packaging protects margin while making the buying path easier to approve.
Assessment Package
Buyers validating workflow pain, governance pressure, record extraction, or AI readiness before a pilot.
- Window: 2 to 4 weeks
- Includes: Workflow Intelligence Assessment, Health Records Safety Assessment, TrustOS AI Governance Audit
- Expansion: Synthetic Pilot Evaluation or Interoperability Readiness Sprint
- Boundary: No live clinical care
Readiness Sprint Package
Teams preparing standards, health-record safety, implementation blueprint, governance, or global readiness before protected work.
- Window: 30 to 45 days
- Includes: Interoperability Readiness Sprint, Clinical Operations Automation Blueprint, Global Certification Readiness Pack
- Expansion: Synthetic Pilot Evaluation or Enterprise Proof and Deal Room Activation
- Boundary: No certified compliance claim
Synthetic Pilot Package
Qualified enterprise buyers ready to evaluate governed workflow intelligence with synthetic evidence.
- Window: 45 to 90 days
- Includes: Synthetic Pilot Evaluation, TrustOS AI Governance Audit, Enterprise Proof and Deal Room Activation
- Expansion: Protected Enterprise Pilot or Enterprise Operating Layer License
- Boundary: Synthetic only
Enterprise Activation Package
Buying committees moving from pilot proof into protected diligence, contract review, implementation, and annual license planning.
- Window: 90 to 180 days depending on buyer controls
- Includes: Enterprise Proof and Deal Room Activation, Clinical Operations Automation Blueprint, Enterprise Operating Layer License
- Expansion: Multi-year enterprise operating license or strategic platform partnership
- Boundary: No contract approval without executive and counsel review
Continuous Review Retainer
Customers or internal teams that need ongoing accuracy, evidence, claims, safety, and innovation review loops.
- Window: Ongoing cadence
- Includes: Continuous Review and Innovation Retainer, TrustOS AI Governance Audit, Enterprise Proof and Deal Room Activation
- Expansion: Enterprise operating cadence, renewal health packet, or internal research roadmap
- Boundary: No managed SOC/MDR claim
Offers
Each offer carries its own buyer trigger, deliverables, proof route, and hard stop.
Workflow Intelligence Assessment
Buyer has a high-friction workflow but is not ready for live data, production connectors, or an enterprise pilot.
- Buyer: Health system operations, access, revenue-cycle, documentation, and transformation leaders
- Deliverables: Workflow friction map for one to three workflows, Automation candidate scorecard, No-PHI evidence inventory and missing-data register
- Gates: Named sponsor, One to three workflow targets, No PHI or production credentials, Buyer-approved measurement questions
- Operational intelligence for human leaders only; no clinical advice, PHI processing, live care, or production automation approval.
Health Records Safety Assessment
Buyer wants extraction, summarization, reconciliation, or source attribution across clinical records without exposing live patient data yet.
- Buyer: CMIO, clinical informatics, health information management, interoperability, privacy, and safety teams
- Deliverables: Document and record-source inventory, FHIR, HL7, DICOM, X12, terminology, and document-type crosswalk, Synthetic extraction test plan
- Gates: No live PHI in discovery, Named privacy or security owner, Source system class identified, Clinical reviewer owner for safety questions
- No-PHI extraction planning only; no patient matching, production connector use, EHR writeback, payer submission, or clinical action.
Interoperability Readiness Sprint
Buyer needs a standards-aware implementation path before committing to a protected pilot or production connector work.
- Buyer: Integration, platform, IT, EHR, payer, data, and architecture teams
- Deliverables: Integration contract review, FHIR, SMART, HL7, DICOM, X12, terminology, and fixture mapping, Synthetic conformance evidence
- Gates: Target standards named, Integration owner assigned, No production endpoint access required, Security and privacy review path known
- Readiness and synthetic conformance only; production connector, PHI, security, and customer environment approval remain external gates.
TrustOS AI Governance Audit
Buyer needs to govern AI adoption, vendor claims, model-risk decisions, and workflow promotion before clinical or operational expansion.
- Buyer: Compliance, privacy, legal, security, clinical governance, innovation, and executive AI oversight teams
- Deliverables: AI governance gap register, Claims and prohibited-language review, Runtime safety and auditability map
- Gates: Governance sponsor, Intended-use language, No confidential policy upload required, Qualified review owner for legal or regulatory conclusions
- Governance readiness only; legal, regulatory, security, certification, and clinical authority require qualified external review.
Synthetic Pilot Evaluation
Buyer has sponsor, review team, workflow scope, decision criteria, and enough budget authority for a 45 to 90 day synthetic pilot.
- Buyer: Enterprise buyers ready to test governed workflow intelligence before live integration
- Deliverables: Synthetic workflow packet, AgentOS task plan and Atlas evidence mapping, TrustOS decision and QA evidence packet
- Gates: Named sponsor, Review team, Approved synthetic packet, No production connector required, Buyer-approved success metrics
- Synthetic evaluation only; no diagnosis, treatment, payer submission, patient outreach, live PHI, or production connector execution.
Clinical Operations Automation Blueprint
Buyer wants a safe automation roadmap before approving protected pilot, staffing, connector, or implementation commitments.
- Buyer: Clinical operations, transformation, care navigation, documentation, revenue-cycle, and public-sector program teams
- Deliverables: Prioritized automation roadmap, Agent responsibility map, Human-review operating design
- Gates: Clinical governance owner, Operations owner, Implementation budget discussion, No live-care authority assumed
- Blueprint planning only; protected pilot, live clinical authority, connectors, staffing, and production procedures require approved scope and controls.
Enterprise Proof and Deal Room Activation
Buyer due diligence requires custom proof packets, evidence rooms, release decisions, security review, and quote-to-contract packaging.
- Buyer: Procurement, security, legal, executive sponsors, investor diligence, and enterprise buying committees
- Deliverables: Buyer proof route map, Diligence packet inventory, Release decision checklist
- Gates: Buyer-specific diligence request, Customer permission path, AAL2 protected workspace owner, Legal and security review owner
- Diligence activation only; buyer-specific external sharing, customer permission, security certification, signed contracts, and production activation remain gated.
Global Certification Readiness Pack
Buyer asks how SCRIMED prepares for HIPAA, SOC 2, HITRUST, ISO, FDA, GDPR, EU AI Act, NHS, MHRA, Australia, or regional procurement gates.
- Buyer: Global health systems, sovereign programs, public-sector buyers, regional partners, and compliance teams
- Deliverables: Global approval and certification track map, Regional buyer pack, Deployment profile and data-boundary assumptions
- Gates: Region or procurement path named, No approval claim requested, Legal, privacy, security, or regional owner assigned, Deployment profile selected
- Readiness-only global planning; local legal, privacy, security, certification, procurement, hosting, and clinical approvals remain external gates.
Continuous Review and Innovation Retainer
Buyer or internal leadership needs ongoing review loops for accuracy, evidence attribution, claims, defects, security drift, and future capability research.
- Buyer: Enterprise sponsors, trust operations, governance teams, product leadership, and internal research stakeholders
- Deliverables: Review loop cadence and ownership map, Accuracy and evidence-attribution issue queue, Claims and public-language drift review
- Gates: Accountable owner, No autonomous remediation promise, No public quantum claim, Human approval path for changes
- Agent-assisted and internal-research cadence only; humans approve remediation, public claims, production changes, and innovation disclosures.
Enterprise Operating Layer License
Buyer has completed protected validation and wants a governed annual or multi-year operating layer across workflows, agents, connectors, support, and governance.
- Buyer: Large health systems, payers, government health agencies, and multi-site healthcare organizations
- Deliverables: Annual license scope, Workflow and agent package plan, Implementation and connector SOW assumptions
- Gates: Protected pilot validated, Security and privacy review path, Legal and finance review, Implementation owner and budget, Customer approval path
- License proposal only until contracts, security, privacy, legal, finance, connector, support, and production authority are approved.
Delivery playbook
Sales, product, trust, legal, finance, and delivery all use the same handoff sequence.
Founder + Revenue Operations
Classify buyer problem, urgency, sponsor, disqualifiers, data boundary, and best-fit package.
- Sponsor, workflow, and no-PHI acknowledgement.
- Selected package, price floor, proof routes, and blocked claims.
- Qualification is not contract approval or clinical approval.
Product Console + Deal Desk
Translate buyer need into offer, deliverables, assumptions, exclusions, owner map, and upgrade path.
- Scope review and decision criteria.
- Scope packet, deliverable list, excluded work, and approval gates.
- Scope packet is not a signed SOW.
Sales Engineering + TrustOS + QA
Attach proof routes, synthetic evidence, QA controls, claims guard, and release boundaries.
- Review team and approved metrics.
- Synthetic proof packet and claims-safe summary.
- Proof is synthetic or readiness-only until protected evidence and customer permission exist.
Deal Desk + Finance + Legal Ops
Move qualified buyer into quote-to-contract, paid diligence, pilot, or enterprise activation.
- Budget owner, procurement route, billing assumptions, and review owners.
- Quote, SOW inputs, price floor, margin estimate, and approval trail.
- Conversion materials are not legal, accounting, tax, or audited financial advice.
Customer Operations + Product + TrustOps
Use retained evidence, adoption signals, support load, safety review, and governance cadence to expand safely.
- Expansion owner, renewal evidence, and approved next workflow.
- Expansion packet, renewal health signal, and next-package recommendation.
- Expansion does not authorize production clinical use, customer public claims, or connector changes without approvals.
Service delivery
Packages are now bound to work-order templates, acceptance criteria, artifacts, and authority gates.
No SCRIMED service should move from buyer interest to delivery without a selected package, no-PHI intake, scope matrix, acceptance criteria, work-order template, proof route, margin control, and retained boundary.
Assessment Package
Synthetic Pilot Evaluation or Interoperability Readiness Sprint
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, workflow-and-system-boundary-map, synthetic-fixture-and-evidence-plan, standards-and-record-safety-crosswalk, trustos-claim-and-authority-review, delivery-retro-expansion-recommendation
- No live clinical care; No PHI; No legal, accounting, tax, security, or regulatory approval; No guaranteed savings
Readiness Sprint Package
Synthetic Pilot Evaluation or Enterprise Proof and Deal Room Activation
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, workflow-and-system-boundary-map, synthetic-fixture-and-evidence-plan, standards-and-record-safety-crosswalk, delivery-retro-expansion-recommendation
- No certified compliance claim; No production connector approval; No regional approval claim; No implementation work without SOW
Synthetic Pilot Package
Protected Enterprise Pilot or Enterprise Operating Layer License
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, synthetic-fixture-and-evidence-plan, trustos-claim-and-authority-review, buyer-proof-packet-release, delivery-retro-expansion-recommendation
- Synthetic only; No autonomous clinical action; No customer-value claim without permission; No protected evidence release without AAL2 gate
Enterprise Activation Package
Multi-year enterprise operating license or strategic platform partnership
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, workflow-and-system-boundary-map, trustos-claim-and-authority-review, buyer-proof-packet-release, delivery-retro-expansion-recommendation
- No contract approval without executive and counsel review; No production activation without customer authority; No PHI without approved BAA/security controls; No margin or revenue guarantee
Continuous Review Retainer
Enterprise operating cadence, renewal health packet, or internal research roadmap
- Templates: buyer-discovery-no-phi-intake, scope-matrix-and-acceptance-plan, trustos-claim-and-authority-review, buyer-proof-packet-release, delivery-retro-expansion-recommendation
- No managed SOC/MDR claim; No error-free AI claim; No autonomous production change; Quantum and frontier research stay internal until approved
Margin controls
Price floors, data boundaries, services separation, and paid diligence keep enterprise work profitable.
Package before custom SOW
Custom buyer requests can sprawl into unpaid discovery or unpriced implementation work.
- Owner: Revenue operations + Product Console
- Hard stops: custom SOW before package selected, unpriced implementation work, unsupported success fee
- Evidence: /offerings, /enterprise-business-ops, /growth-engine
Data-boundary price floor
PHI, sandbox, connector, or production requests create security, review, support, and liability costs.
- Owner: Finance + Legal Ops + Privacy
- Hard stops: PHI requested, production connector requested, BAA/security scope missing
- Evidence: /health-records, /clinical-authority-readiness, /enterprise-business-ops
Diligence work monetization
Security, legal, procurement, and investor packets can become unpaid enterprise sales labor.
- Owner: Buyer Diligence + Sales Operations
- Hard stops: custom packet work without paid scope, external sharing before release decision, recipient controls missing
- Evidence: /pilot-deal-room, /pilot-workspace/access, /buyer-release-control-run
License and services separation
High-touch services can erode platform license margin if bundled into the annual fee.
- Owner: Finance + Product + Implementation
- Hard stops: services bundled into license, support tier undefined, implementation acceptance criteria missing
- Evidence: /pricing, /enterprise-business-ops, /public-market-readiness
Claims review before proof expansion
Unsupported ROI, reimbursement, customer value, certification, or investor claims can create legal and trust risk.
- Owner: Claims governance + Counsel + Finance
- Hard stops: ROI guarantee, reimbursement guarantee, customer claim without permission, certification claim without authority
- Evidence: /qa-claim-guard, /boundary-resolution, /public-market-readiness
Model cost and usage review
Large-context extraction, repeated evaluations, and proof-packet generation can silently compress margins.
- Owner: Product Engineering + Finance
- Hard stops: uncapped high-volume usage, model-cost spike, usage threshold missing
- Evidence: /service-reliability, /operational-efficiency, /public-market-readiness
Global partner economics review
Partner discounts, reseller terms, regional hosting, tax exposure, and delivery obligations can erode margin.
- Owner: Strategic Partnerships + Finance + Tax + Regional Counsel
- Hard stops: cross-border margin-sharing commitment, regional tax review missing, partner delivery owner missing
- Evidence: /global-reach, /global-certification-readiness, /enterprise-business-ops
Retainer escalation scope
Continuous review can turn into unbounded remediation, support, or innovation work.
- Owner: TrustOps + Product + Revenue Operations
- Hard stops: autonomous remediation promised, managed SOC/MDR claim, implementation work hidden in retainer
- Evidence: /continuous-review-audit, /service-reliability, /operational-efficiency
Boundary resolutions
Workarounds are explicit, so delivery can move without crossing healthcare, legal, financial, or approval gates.
Offer sprawl and buyer confusion
Route every buyer conversation to /offerings before pricing, pilot, diligence, or implementation scope expands.
- Buyers, sales, delivery, and reviewers may discuss different scopes, causing slower deals and higher delivery risk.
- Gate: Buyer-specific SOW, price, payment terms, and approval trail before commitment.
- Owner: Product Console + Revenue Operations
Custom scope margin leakage
Offer a capped assessment, readiness sprint, synthetic pilot, or paid diligence package before custom SOW work.
- Enterprise urgency can move SCRIMED into unpaid diligence, weak payment terms, or unpriced implementation labor.
- Gate: Finance, legal, executive, and customer approval for custom scope and payment terms.
- Owner: Finance + Legal Ops + Deal Desk
Buyer asks for PHI, live records, connectors, EHR writeback, or payer submission
Use synthetic fixtures, metadata-only system descriptions, sandbox planning, source attribution, and live-data gate mapping.
- Unsafe data exposure or unauthorized healthcare action could cross privacy, security, clinical, reimbursement, and connector boundaries.
- Gate: BAA/privacy/security approval, customer environment approval, clinical authority, connector acceptance, payer or EHR authorization as applicable.
- Owner: Privacy + Security + Interoperability + Clinical Governance
ROI, reimbursement, customer value, and revenue overclaim
Use measured pilot signals, directional workflow metrics, and readiness-only language until customer permission and qualified review exist.
- Sales, investor, or buyer language could outrun evidence and create legal, trust, reimbursement, or securities risk.
- Gate: Buyer-approved baseline, retained measurement evidence, customer permission, counsel review, finance review, and release decision.
- Owner: Claims Governance + Finance + Counsel + Customer Sponsor
Certification, approval, and regional authority overclaim
Package readiness tracks, blocked claims, evidence gaps, and external-review owners without saying approval exists.
- SCRIMED could appear to claim HIPAA, SOC 2, HITRUST, FDA, ONC, GDPR, EU AI Act, NHS, MHRA, Australia, or regional approval before qualified evidence exists.
- Gate: Qualified external authority, applicable audit or certification process, regional counsel, security/privacy review, and buyer-specific acceptance.
- Owner: Legal + Security + Privacy + Regional Counsel + Qualified Reviewers
Continuous review and innovation overclaim
Use agents to flag, route, recommend, and preserve evidence; keep humans in charge of changes and keep quantum research internal.
- 24/7 review loops or internal research could be mistaken for error-free AI, managed SOC/MDR coverage, autonomous remediation, or public quantum capability.
- Gate: Human approval, security review, customer permission, evidence retention, and claims review before public or production use.
- Owner: TrustOps + QA + Security + Internal Research Team